Cite
MLA Citation
R. Nishimura et al.. “Effects of luseogliflozin, a sodium–glucose co‐transporter 2 inhibitor, on 24‐h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double‐blind, placebo‐controlled, crossover study.” Diabetes, obesity & metabolism, vol. 17, no. 8, n.d., pp. 800–804. http://access.bl.uk/ark:/81055/vdc_100025991362.0x00001f